A triple blind, placebo controlled, randomised controlled trial of betahistine dihydrochloride in the treatment of primary tinnitus.

Gustavo Leão Castilho Norimar Hernanes Dias Regina Helena Garcia Martins

Published in: Clinical otolaryngology : official journal of ENT-UK ; official journal of Netherlands Society for Oto-Rhino-Laryngology & Cervico-Facial Surgery (2022)

Betahistine dihydrochloride was ineffective in the treatment of primary tinnitus in adults.

Keyphrases

study protocol
clinical trial
combination therapy
radiation therapy
double blind
hearing loss
open label
phase ii
phase ii study
phase iii